Infectious Agents and Cancer
- Funding Opportunities
- Funded Projects
- Research Resources
- Public Resources
- Selected Publications
- EGRP-Supported Webinar Series
An estimated 16.1% of newly diagnosed cancers may be attributable to infections. Our knowledge of the underlying mechanisms of cancer induction by infectious agents, interactions between the environment and host genetics, and potential roles of cofactors (known and unknown) is limited and warrants further elucidation. Moreover, technological advances have led to the discovery of previously unknown and unsuspected oncogenic infections in recent years, prompting the idea that additional infection-associated cancers might still be discovered. Epidemiologic studies on this topic could play important roles in answering both old and new questions, which could augment current knowledge and open new areas of research. Understanding the role of infection in cancer may result in discoveries that lead to better diagnosis, prevention, and treatment of cancers, particularly in resource-poor countries.
NCI-sponsored Funding Opportunity Announcements (FOAs) related to infectious diseases and risk of cancer include:
- HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research - expires May 8, 2020, unless reissued
- "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers – expires September 8, 2019, unless reissued
- International Research in Infectious Diseases, including AIDS - expires August 23, 2019, unless reissued
- PAR-17-142 (R01)
EGRP encourages investigator-initiated grant applications on infectious agents and cancer. It also joins with other NCI Divisions, and other components of the National Institutes of Health (NIH) to fund grant applications submitted in response to FOAs. View the full list of EGRP FOAs.
The NIH's National Institute of Allergy and Infectious Diseases (NIAID) also contains information about research funding opportunities related to infectious agents.)
NIH has also partnered with the International AIDS Society and the NIH-funded Centers for AIDS Research to support innovative research projects to introduce scientists from other disciplines to the field of HIV research.
- AIDS and Cancer Specimen Resource
A collection of tissues and biological fluids with associated clinical and follow-up data from patients with HIV-related malignancies. Specimens and clinical data are available for research studies, particularly those that translate basic research findings to clinical application.
- Center for AIDS Research (CFAR) Network of Integrated Clinical Systems
Provides integrated clinical data from the large and diverse population of HIV-infected people in the modern HIV/AIDS Alliance for Region Two (HAART) era who are receiving care at one of the many U.S. federally funded CFAR sites and data to address the challenging and rapidly evolving issues in HIV care and research.
- National Institute of Allergy and Infectious Diseases (NIAID) Research Resources
A compilation of scientific literature, laboratory and clinical research support and tools, and training opportunities.
- NIH Common Fund Human Microbiome Project
Provides links to funding opportunities and research resources enabling comprehensive characterization of the human microbiota and analysis of their role in human health and disease.
- NCI Fact Sheets
- Key NCI information on disease incidence and mortality, funding, research activities, and recent scientific advances can be found at NCI's Snapshots website:
- CDC Preventing Infections in Cancer Patients
- National Center for Health Statistics Data Brief (April 2017): Prevalence of HPV in Adults Aged 18-69 in the U.S. [PDF]
- World Health Organization - Global Health Observatory
Links to reports containing statistics for key health indicators on an annual basis
- Bui TC, Tran LT, Thai TN, Shete SS, Vidrine DJ, Sturgis EM. Prevalence of and risk factors for oral human papillomavirus infection with multiple genotypes in the United States. Sex Transm Dis. 2017 Mar;44(3):166-172.
- Bartenhagen C, Fischer U, Korn K, Pfister SM, Gombert M, Chen C, Okpanyi V, Hauer J, Rinaldi A, Bourguin JP, Eckert C, Hu J, Ensser A, Dugas M, Borkhardt A. Infection as a cause of childhood leukemia - virus detection employing whole genome sequencing. Haematologica. 2017 Feb 2.
- Casper C, Fitzmaurice C. Infection-related cancers: prioritising an important and eliminable contributor to the global cancer burden. Lancet Glob Health. 2016 Sep;4(9):e580-1.
- Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016 Sep;4(9):e609-16.
- Vedham V, Divi RL, Starks VL, Verma M. Multiple infections and cancer: implications in epidemiology. Technol Cancer Res Treat. 2014 April;13(2):177-94.
- de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012 Jun;13(6):607-15.
- De Flora S, Bonanni P. The prevention of infection-associated cancers. Carcinogenesis. 2011 Jun;32(6):787-95.
- de Martel C, Franceschi S. Infections and cancer: established associations and new hypotheses. Crit Rev Oncol Hematol. 2009 Jun;70(3):183-94.
- IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Biological agents. Volume 100B. Lyon (France): IARC; 2007.
- IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 90. Human Papillomaviruses. Lyon (France): IARC; 2007.
- Pagano JS, Blaser M, Buendia MA, Damania B, Khalili K, Raab-Traub N, Roizman B. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol. 2004 Dec;14(6):453-71.
- Kinlen L. Infections and immune factors in cancer: the role of epidemiology. Oncogene. 2004 Aug 23;23(38):6341-8.
EGRP-Supported Webinar Series
- Hamdi Abdi, M.P.H. – underserved/under-researched populations, global health, refugee/immigrant health, maternal and child health
- Katy Brignole, M.Sc. – global health, health inequities, social epidemiology, spatial-temporal epidemiology, infectious agents and cancer, mixed methods research
- Danielle M. Carrick, Ph.D., M.H.S. - biospecimen research, immunology and inflammation related to cancer risk
- Allison Cook – cancer and the environment, global health, risk communication about environmental public health, long-term effects of exposure to radiation and toxins, food security, urban public health systems
- Gary L. Ellison, Ph.D., M.P.H.
- Gabriel Lai, Ph.D. - hepatitis viruses, Epstein-Barr virus, Helicobacter pylori (H. pylori)
- Tram Kim Lam, Ph.D., M.P.H. - environmental exposures, health disparities, understudied populations, infection-related cancers
- Damali N. Martin, Ph.D., M.P.H. - health disparities, global health, understudied populations
- Vaurice L. Starks, B.S. - HIV-related malignancies studies, HPV infection and associated cancers, virally-mediated carcinogenesis
- Mukesh Verma, Ph.D. - biomarkers, epigenetics, risk assessments